Zebra Capital Management’s Amedisys AMED Stock Holding History

Zebra Capital Management’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-5,522	Closed	-$724K	–	294
2019 Q3	$724K	Sell	5,522 -1,888	-25%	-$246K	0.79%	29
2019 Q2	$900K	Sell	7,410 -1,692	-19%	-$201K	0.47%	42
2019 Q1	$1.12M	Buy	9,102 +672	+8%	+$84.3K	0.6%	23
2018 Q4	$987K	Sell	8,430 -94	-1%	-$11.1K	0.61%	19
2018 Q3	$1.06M	Sell	8,524 -4,162	-33%	-$460K	0.49%	29
2018 Q2	$1.08M	Sell	12,686 -6,590	-34%	-$484K	0.46%	35
2018 Q1	$1.16M	Sell	19,276 -655	-3%	-$37.3K	0.42%	85
2017 Q4	$1.05M	Buy	19,931 +3,374	+20%	+$178K	0.36%	131
2017 Q3	$927K	Buy	+16,557	New	+$876K	0.3%	162

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

Zebra Capital Management's AMED Position: Q4 2019 in Review

Zebra Capital Management sold out of Amedisys (AMED) in Q4 2019, closing a stake of 5,522 shares — an estimated $724K sold.

Zebra Capital Management first reported a position in AMED in Q3 2017 and held it in 9 quarters. The position peaked at $1.16M in Q1 2018. 325 funds tracked by Wall St. Rank hold AMED as of Q4 2019.

Zebra Capital Management reported no remaining Amedisys position as of Q4 2019 after selling out during the quarter.
Zebra Capital Management sold 5,522 Amedisys shares in Q4 2019, an estimated $724K.
Zebra Capital Management first reported a position in Amedisys in Q3 2017 and held it in 9 quarters.
Zebra Capital Management's Amedisys position peaked at $1.16M in Q1 2018.
325 funds tracked by Wall St. Rank held Amedisys as of Q4 2019.

Based on Zebra Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.